Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Key Ratios

Key Ratios

Price & Volume

Recent Price $11.00
52 Week High $14.60
52 Week Low $5.50
Volume (10 Day Average) (Mil) $0.25
Beta $-0.16

Dividends

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Current Ratio (MRQ) $4.65
LT Debt to Equity (MRQ) (%) --
Total Debt to Equity (MRQ) (%) --

Valuation

P/E (TTM) --
Price to Revenue (TTM) $232.20
Price to Cash Flow (TTM) --
Price to Book (MRQ) $3.46

Per Share

Revenue/Share (TTM) $0.06
EPS Fully Diluted (MRQ) $-0.66
Book Value/Share (MRQ) $3.18
Cash Flow/Share (TTM) $-2.47
Cash (MRQ) $2.55

Management Effectiveness

Return on Equity (TTM) (%) -65.34
Return on Assets (TTM) (%) -56.70
Return on Investment (TTM) (%) -65.15

Profitability

Operating Margin (TTM) (%) -4,220.23
Net Profit Margin (TTM) (%) -4,171.28
Gross Margin (TTM) (%) --


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved